Germana Bancone
Overview
Explore the profile of Germana Bancone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gilder M, Saito M, Haohankhunnatham W, Ling C, Gornsawun G, Bancone G, et al.
PLoS Med
. 2025 Mar;
22(3):e1004529.
PMID: 40036207
Background: Malaria in pregnancy detected by microscopy is associated with maternal anaemia, reduced fetal growth, and preterm birth, but the effects of lower density (i.e., submicroscopic) malaria infections are poorly...
2.
Watson J, Mehdipour P, Moss R, Jittamala P, Zaloumis S, Price D, et al.
Antimicrob Agents Chemother
. 2025 Feb;
:e0154924.
PMID: 39992119
Primaquine is the only widely available drug to prevent relapses of malaria. Primaquine is underused because of concerns over oxidant hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficiency. A pharmacometric trial showed...
3.
Bancone G, Gilder M, Win E, Gornsawun G, Moo P, Archasuksan L, et al.
BMJ Paediatr Open
. 2024 Sep;
8(1).
PMID: 39343446
Background: Neonatal hyperbilirubinaemia (NH) is a common problem worldwide and is a cause of morbidity and mortality especially in low-resource settings. Methods: A study was carried out at Shoklo Malaria...
4.
Luzzatto L, Bancone G, Dugue P, Jiang W, Minucci A, Nannelli C, et al.
Bull World Health Organ
. 2024 Jul;
102(8):615-617.
PMID: 39070600
No abstract available.
5.
Bancone G, Poe D, Gornsawun G, Htway P, Gilder M, Archasuksan L, et al.
Wellcome Open Res
. 2024 Feb;
7:273.
PMID: 38406309
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency represents a barrier to the full deployment of anti-malarial drugs for vivax malaria elimination and of first-line antibiotics. Lack of established reference ranges for G6PD...
6.
Pukrittayakamee S, Jittamala P, Watson J, Hanboonkunupakarn B, Leungsinsiri P, Poovorawan K, et al.
Elife
. 2024 Feb;
12.
PMID: 38319064
Background: Primaquine is an 8-aminoquinoline antimalarial. It is the only widely available treatment to prevent relapses of malaria. The 8-aminoquinolines cause dose-dependent haemolysis in glucose-6-phosphate dehydrogenase deficiency (G6PDd). G6PDd is...
7.
Adissu W, Brito M, Garbin E, Macedo M, Monteiro W, Mukherjee S, et al.
PLoS Negl Trop Dis
. 2023 Oct;
17(10):e0011652.
PMID: 37824592
Introduction: Screening for G6PD deficiency can inform disease management including malaria. Treatment with the antimalarial drugs primaquine and tafenoquine can be guided by point-of-care testing for G6PD deficiency. Methods And...
8.
Rajasekhar M, Simpson J, Ley B, Edler P, Chu C, Abreha T, et al.
Lancet Infect Dis
. 2023 Sep;
24(2):184-195.
PMID: 37748497
Background: Primaquine radical cure is used to treat dormant liver-stage parasites and prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We undertook a systematic review and...
9.
Taylor W, Meagher N, Ley B, Thriemer K, Bancone G, Satyagraha A, et al.
PLoS Negl Trop Dis
. 2023 Sep;
17(9):e0011522.
PMID: 37672548
Background: The World Health Organization recommends that primaquine should be given once weekly for 8-weeks to patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase (G6PD) deficiency, but data on its...
10.
Fanello C, Lee S, Bancone G, Kayembe D, Ndjowo P, Badjanga B, et al.
Am J Trop Med Hyg
. 2023 Sep;
109(4):965-974.
PMID: 37669757
Neonatal hyperbilirubinemia (NH) is a frequent condition that, if left untreated, can lead to neurological disability and death. We assessed the prevalence of NH and associated neonatal and maternal risk...